Bausch + Lomb has announced the acquisition of two eye drops’ brands in the last two weeks as the company is aiming to expand its catalog of over-the-counter (OTC) eye care solutions. The first acquisition is the takeover of Xiidra, an eye-drop solution for the treatment of dry eye disease, ...
Buying a membership today will give you:
To continue reading this article register now.